THE ROLEOF A SPORT IN A HEALTHY LIFESTYLE
Abstract
The COVID-19 pandemic has significantly impacted not only global healthcare systems but also the human body. The SARS-CoV-2 virus damages both the upper and lower respiratory tracts, leading to severe inflammatory processes in the lungs. The acute and chronic phases of this disease can cause serious pathological conditions such as alveolar damage, microthrombosis, and fibrosis.
This article provides a comprehensive review of the morphological and pathological changes in the lungs due to COVID-19, explaining how the virus affects alveolar cells, triggers inflammatory processes, and leads to long-term complications.
References
Zhu, N., Zhang, D., Wang, W., et al. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727-733.
Carsana, L., Sonzogni, A., Nasr, A., et al. (2020). Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy. The Lancet Infectious Diseases, 20(10), 1135-1140.
Ackermann, M., Verleden, S. E., Kuehnel, M., et al. (2020). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. The New England Journal of Medicine, 383(2), 120-128.
Xu, Z., Shi, L., Wang, Y., et al. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine, 8(4), 420-422.
Varga, Z., Flammer, A. J., Steiger, P., et al. (2020). Endothelial cell infection and endotheliitis in COVID-19. The Lancet, 395(10234), 1417-1418.
